Raymond James Financial Inc. Takes Position in Teleflex Incorporated (NYSE:TFX)

Raymond James Financial Inc. bought a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 58,108 shares of the medical technology company's stock, valued at approximately $10,342,000. Raymond James Financial Inc. owned about 0.13% of Teleflex as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Janus Henderson Group PLC lifted its stake in shares of Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock valued at $1,329,704,000 after purchasing an additional 147,147 shares during the period. FMR LLC lifted its stake in Teleflex by 70.1% in the third quarter. FMR LLC now owns 269,490 shares of the medical technology company's stock valued at $66,650,000 after buying an additional 111,086 shares during the period. Point72 Asset Management L.P. boosted its holdings in shares of Teleflex by 31.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company's stock worth $100,768,000 after buying an additional 96,958 shares in the last quarter. Parkman Healthcare Partners LLC acquired a new stake in shares of Teleflex during the 3rd quarter worth approximately $23,778,000. Finally, Robeco Institutional Asset Management B.V. increased its stake in shares of Teleflex by 1,401.5% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 41,726 shares of the medical technology company's stock valued at $7,426,000 after acquiring an additional 38,947 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on TFX shares. Bank of America cut shares of Teleflex from a "neutral" rating to an "underperform" rating and reduced their price target for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Royal Bank of Canada downgraded Teleflex from an "outperform" rating to a "sector perform" rating and reduced their target price for the company from $220.00 to $155.00 in a research note on Friday, February 28th. Wells Fargo & Company dropped their price target on Teleflex from $214.00 to $146.00 and set an "equal weight" rating on the stock in a research note on Friday, February 28th. Truist Financial reduced their price objective on Teleflex from $200.00 to $149.00 and set a "hold" rating for the company in a research note on Monday, March 3rd. Finally, Citizens Jmp lowered Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Teleflex has an average rating of "Hold" and an average price target of $182.63.

Teleflex Stock Up 0.0 %

Teleflex stock traded up $0.06 during trading on Monday, hitting $141.62. 1,276,248 shares of the company were exchanged, compared to its average volume of 548,688. The company has a market capitalization of $6.57 billion, a P/E ratio of 28.16, a PEG ratio of 1.73 and a beta of 1.21. The business's 50 day moving average is $163.17 and its 200 day moving average is $193.68. Teleflex Incorporated has a 52 week low of $128.55 and a 52 week high of $249.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX - Get Free Report) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 0.96%. Teleflex's dividend payout ratio (DPR) is 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.